Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | N/A | N/A |
PEG Ratio (TTM) | N/A | N/A |
P/S Ratio (TTM) | 0.00 | N/A |
P/B Ratio (TTM) | N/A | N/A |
P/FCF Ratio (TTM) | 0.51 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | -2.10 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.65% | N/A |
ROE (TTM) | -17.62% | N/A |
Net Profit Margin (TTM) | -4.79% | N/A |
ROIC 5YR AVG | -14.45% | N/A |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -182.08% | -177.93% | -132.98% |
Revenue | -31.80% | 7.39% | 9.81% |
Net Income | -181.25% | -115.47% | -110.62% |
Cash Flow | -25.36% | -97.13% | -608.30% |
Health (28%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.45 | N/A |
Quick Ratio (TTM) | 1.18 | N/A |
D/E Ratio (TTM) | 0.57 | N/A |
Interest Coverage (TTM) | -3.76 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.81 | N/A |
Shares Outstanding Growth 5YR AVG | 2.59% | N/A |